| Abstrakt: |
A recent study from Maastricht University explores the transcriptomic and epigenomic changes in the tryptophan catabolic pathway in Alzheimer's disease (AD). The research identified key genes associated with AD, such as IDO2, which could serve as potential biomarkers and therapeutic targets for the disease. This study sheds light on the molecular alterations in AD and emphasizes the importance of further investigation into these pathways for potential treatment strategies. [Extracted from the article] |
